Lower Afib Risk Regardless of Weight Researchers at UVA Health analyzed data from 12,812 patients treated with GLP-1s between 2020 and 2023
Tirzepatide has been studied in the literature in relation to body-weight outcomes, appetite regulation, glycaemic control, insulin signalling and incretin biology
Neuropathy is a condition that affects millions globally, causing numbness, tingling, and pain
Authoritative Sources For official prescribing details, review the FDA Wegovy label
Some men transition from a full dose to a GLP-1 maintenance dose after reaching their goal weight
Both case reports regarding the first uses of liraglutide in treating HS revealed a significant decrease in lesion severity and presence